Published in AIDS Weekly, December 13th, 2004
Retrovir and Epivir are available as Combivir (lamivudine and zidovudine), which delivers a fixed-dose combination of both NRTIs in a single tablet taken twice daily (BID) with or without food. The recommendations, developed by the U.S. Department of Health and Human Services (DHHS), were recently updated and published (October 29, 2004).
Dual nucleoside combinations are the most frequently used foundation of combination...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.